ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,643 | -87.1% | 50,400 | -50.0% | 0.00% | – |
| Q2 2023 | $51,408 | -19.0% | 100,800 | 0.0% | 0.00% | – |
| Q1 2023 | $63,504 | +317420.0% | 100,800 | +231.6% | 0.00% | – |
| Q4 2022 | $20 | -100.0% | 30,400 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | +2.0% | 30,400 | -26.7% | 0.00% | – |
| Q2 2022 | $51,000 | +88.9% | 41,490 | 0.0% | 0.00% | – |
| Q1 2022 | $27,000 | -40.0% | 41,490 | 0.0% | 0.00% | – |
| Q4 2021 | $45,000 | -40.0% | 41,490 | +0.5% | 0.00% | – |
| Q3 2021 | $75,000 | -30.6% | 41,290 | +1.0% | 0.00% | – |
| Q2 2021 | $108,000 | -26.5% | 40,865 | 0.0% | 0.00% | – |
| Q1 2021 | $147,000 | +38.7% | 40,865 | -2.5% | 0.00% | – |
| Q4 2020 | $106,000 | +86.0% | 41,905 | +85.0% | 0.00% | – |
| Q3 2020 | $57,000 | +1040.0% | 22,655 | +1228.7% | 0.00% | – |
| Q2 2018 | $5,000 | -93.6% | 1,705 | -91.4% | 0.00% | – |
| Q1 2018 | $78,000 | 0.0% | 19,840 | +5.3% | 0.00% | – |
| Q4 2017 | $78,000 | – | 18,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |